Recommendations on choice of therapeutic products for the treatment of patients with haemophilia A, haemophilia B and von Willebrands disease. Review of recent scientific data on coagulation concentrate concentrate therapy and changes in availability, licensing status and pricing structure of therapeutic materials in the context of the recently implemented NHS reforms. Tables Factor VIII/Factor IX concentrates in UK.